The Center for Networked Biomedical Research in Cancer (CIBERONC) (Spain), through the research group led by Xosé R. Bustelo, also belonging to the Cancer Research Center of Salamanca, has just discovered that the VAV1 gene, usually involved in the formation of a wide range of tumors, can also play roles involved in the suppression of some specific types of acute lymphoblastic leukemia of T lymphocytes.

This leukemia is the most frequent pediatric cancer and, even today, it poses many challenges for an adequate diagnosis and treatment. This discovery has just been published in the prestigious scientific journal Cancer Cell. T-lymphocytes are cells of the immune system whose function is to recognize and destroy cells from our organs that have become cancerous or that have been infected by viruses or other pathogens. They are also in charge of regulating other cells of the immune system, which are involved in the destruction of any external agent that invades our body, such as chemicals or bacteria. Despite these positive functions, T lymphocytes undergo in some cases genetic alterations that  turn them from protective agents to malignant cells that cause tumors.


News published in the media:



Posted by Juan M. Corchado

Catedrático en el Área de Ciencias de la Computación e Inteligencia Artificial de la Universidad de Salamanca. Director del Grupo de Investigación BISITE // Full Professor in Area of Computer Science and Artificial Intelligence at University of Salamanca. Director of the BISITE Research Group

Thanks for your comment

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.